Title |
Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice
|
---|---|
Published in |
BMC Neuroscience, April 2013
|
DOI | 10.1186/1471-2202-14-44 |
Pubmed ID | |
Authors |
Sandra Sivilia, Luca Lorenzini, Alessandro Giuliani, Marco Gusciglio, Mercedes Fernandez, Vito Antonio Baldassarro, Chiara Mangano, Luca Ferraro, Vladimiro Pietrini, Maria Francesca Baroc, Arturo R Viscomi, Simone Ottonello, Gino Villetti, Bruno P Imbimbo, Laura Calzà, Luciana Giardino |
Abstract |
Alzheimer disease is a multifactorial disorder characterized by the progressive deterioration of neuronal networks. The pathological hallmarks includes extracellular amyloid plaques and intraneuronal neurofibrillary tangles, but the primary cause is only partially understood. Thus, there is growing interest in developing agents that might target multiple mechanisms leading to neuronal degeneration. CHF5074 is a nonsteroidal anti-inflammatory derivative that has been shown to behave as a γ-secretase modulator in vitro and to inhibit plaque deposition and to reverse memory deficit in vivo in transgenic mouse models of Alzheimer's disease (AD). In the present study, the effects of a long-term (13-month) treatment with CHF5074 on indicators of brain functionality and neurodegeneration in transgenic AD mice (Tg2576) have been assessed and compared with those induced by a prototypical γ-secretase inhibitor (DAPT). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 2% |
Unknown | 89 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 19% |
Student > Master | 17 | 19% |
Student > Ph. D. Student | 15 | 16% |
Other | 10 | 11% |
Student > Bachelor | 5 | 5% |
Other | 11 | 12% |
Unknown | 16 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 20 | 22% |
Biochemistry, Genetics and Molecular Biology | 12 | 13% |
Medicine and Dentistry | 12 | 13% |
Neuroscience | 7 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 7% |
Other | 15 | 16% |
Unknown | 19 | 21% |